Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
45%
Total
Publications
1.8K
Total Open
Publications
805
Total
Citations
91K
Open Access
Percentage
45%
Total
Publications
1.8K
Total Open
Publications
805
Total
Citations
91K
Breakdown
Publisher Open
16%
Both
18%
Other Platform Open
11%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 26%
160
Hybrid 39%
239
No Guarantees 35%
217
Other Platform Open
Domain 82%
425
Institution 31%
162
Preprint 10%
53
Other Internet 9%
44
Public 7%
34
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 428 |
Europe PMC | Domain | 286 |
DOI | Other Internet | 51 |
Semantic Scholar | Public | 27 |
bioRxiv | Preprint | 25 |
Research Square | Preprint | 18 |
Imperial College London - Spiral | Institution | 18 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 16 |
University of California - eScholarship University of California | Institution | 16 |
University of Bristol - Bristol Research | Institution | 13 |